About Careers MedBlog Contact us

Research Shows Muscle Cramp Drug Prevents Strokes Better Than Aspirin

by Thilaka Ravi on September 11, 2010 at 6:12 PM
Font : A-A+

 Research Shows Muscle Cramp Drug Prevents Strokes Better Than Aspirin

According to a new research, a drug used to ease cramp is more effective at preventing strokes than aspirin.

During the study, scientists discovered that the drug reduced the risk of a stroke by a quarter and the risk of dangerous side-effects by a half in patients, reports the Telegraph.


The findings are particularly important as millions of people take a low dose of aspirin daily, as it is known to reduce the risk of having a heart attack or stroke in people, especially if they have already had one.

Taking cilostazol, a drug which prevents clotting and is used to treat muscle cramps, instead would not only be more powerful but also reduce the risk of haemorrhage - one of the major dangers of taking aspirin.

Authors Dr Deepak Bhatt and Dr Dharam Kumbhani of Harvard Medical School, said the trial suggested that cilostazol offered "prevention beyond the protection provided by aspirin".

In the study, 2757 patients who had already suffered a stroke were split into two roughly equal groups - one of which was given aspirin and the other cilostazol for as long as five years.

During the trial, it was found that 2.76 per cent of the cilostazol group suffered a stroke compared to 3.71 per cent of the aspirin group - a 26 per cent reduction.

Severe bleeding occurred in half as many patients taking cilostazol - 077 per cent per year - compared to patients taking aspirin - 178 per cent per year.

However, non-serious side-effects including headache, diarrhoea, palpitation, and dizziness, were significantly more common in the cilostazol group.

The authors of the study said that more trials were needed to see that the effect was universal as the trial was carried out in Japan.

The study has been published in the Lancet.

Source: ANI


Recommended Reading

Latest Drug News

 FDA Issues Warning About Compounded Diabetes Drug Semaglutide Products
The FDA advises consumers not to use compounded medications as an alternative to known diabetic and weight reduction medications Ozempic, Rybelsus, and Wegovy.
 Parkinson's Unmet Needs Creates Path for New Entrants into the Market
Addressing the unmet needs of Parkinson's Disease by providing disease-modifying therapies could bring about a major shift in the way that patients are treated.
How Microrobots Could Help Treat Bladder Diseases?
Microrobots could swirl through a person's blood stream, search for targeted areas to treat for various ailments.
How Can Multivitamin Supplements Slow Cognitive Aging?
Supplementation with multivitamins is an inexpensive way for older adults to slow down memory loss.
 Ivosidenib Approved for Acute Myeloid Leukemia & Advanced Cholangiocarcinoma
Some people with an aggressive blood cancer called acute myeloid leukemia (AML) may soon have a new drug option called Ivosidenib that blocks the activity of IDH1 gene.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Research Shows Muscle Cramp Drug Prevents Strokes Better Than Aspirin Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests